Cardinal Health
Cardinal Health is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Cardinal Health.
Cardinal Health is a company.
Key people at Cardinal Health.
Cardinal Health, Inc. is a global healthcare services and products company headquartered in Dublin, Ohio, primarily operating as a distributor of pharmaceuticals and a manufacturer and distributor of medical and laboratory products.[4][5] It serves hospitals, healthcare systems, pharmacies, and laboratories across nearly every U.S. state and over 30 countries, with two main segments: Pharmaceutical (supplying branded, generic, and specialty drugs) and Medical (providing surgical products, supply chain solutions, and nuclear pharmacy services).[2][5] Generating $181.4 billion in annual sales in 2022 with about 48,000 employees, the company drives efficiency in healthcare supply chains and supports patient care through innovations like inventory management and direct-to-patient services.[4][5]
Cardinal Health traces its roots to 1971, when founder Robert D. Walter, a 26-year-old Harvard graduate, purchased the struggling Ohio-based Monarch Foods for $135,000 cash plus $1.3 million in debt, renaming it Cardinal Foods after Ohio's state bird.[1][3][4] After moderate success in grocery distribution, including a brief supermarket venture amid challenges like a salmonella outbreak, Walter pivoted in 1979-1980 by acquiring Bailey Drug Company for $4.4 million, shifting fully to pharmaceutical distribution and renaming to Cardinal Distribution, Inc.[1][2][3] Key milestones include its 1983 NASDAQ IPO at $1.03 per share after Walter bought out investors, the 1994 name change to Cardinal Health, and aggressive acquisitions like Allegiance (1999, $5.4 billion for medical products), Syncor (2003 for nuclear pharmacy), and Cordis (2015 for vascular tech).[1][2][3] Mike Kaufmann joined in 1990 and became CEO, leading through spin-offs like the 2009 clinical products divestiture.[1][4]
Cardinal Health anchors the healthcare supply chain amid rising demand for efficient drug and medical product distribution, fueled by aging populations, chronic disease prevalence, and post-pandemic supply vulnerabilities.[2][5] Its timing leverages the 1970s-1980s pharma boom and consolidations, evolving from wholesaler to integrated provider as hospitals seek one-stop solutions for inventory, manufacturing, and data analytics.[3] Market forces like generic drug shifts, specialty pharma growth, and regulatory pressures (e.g., opioid initiatives under CEO Kaufmann) favor its scale, while it influences the ecosystem by enabling cost savings and tech integrations like inventory software, reducing waste in a $4+ trillion U.S. healthcare market.[4][5]
Cardinal Health's essential role in healthcare infrastructure positions it for steady growth, with trends like AI-driven supply chains, biologics expansion, and global health resilience likely boosting its data solutions and specialty distribution.[2][5] Expect continued M&A to deepen medtech and home care, alongside opioid mitigation efforts, potentially elevating its influence as a stability provider amid volatility. From Robert Walter's bold grocery-to-pharma pivot, it remains a cornerstone of care delivery.[1][4]
Key people at Cardinal Health.
